Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why diabetes and weight loss drugs work better than alcohol medications.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

His attacks have grown more sweeping, with Kennedy suggesting he will clear out “entire departments” at FDA, including the ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

The Food and Drug Administration told CBS News it cannot comment ... main ingredient semaglutide. FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...